Edwards Lifesciences | EW - Nettoeinkommen

Aktienkurs
81.04
Täglich Wechseln
-0.22 -0.27%
Monatlich
-4.97%
Jährlich
11.04%
Q2 Prognose
76.96




Nettoeinkommen Veränderung Datum
Abbott USD 1.78B 132M 2025-12
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Hologic USD 179.1M 8.2M 2025-12
ICU Medical USD -15.73M 12.34M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
J&J USD 5.12B 36M 2025-12
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12